Inmed appoints cbiz as new auditor in connection with cbiz's acquisition of marcum's attest business, provides update on special meeting and makes modifications to existing sepa

Vancouver, british columbia--(newsfile corp. - june 13, 2025) - inmed pharmaceuticals inc. (nasdaq: inm) ("inmed" or the "company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced that marcum llp has resigned as inmed's auditor following the acquisition of marcum's attest business by cbiz cpas p.c., with an effective resignation date of june 12, 2025 (the "marcum acquisition").
CBZ Ratings Summary
CBZ Quant Ranking